Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Morphine (substance) |
Is a |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing phenanthrene derivative (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
1 |
Phenanthrene derivative poisoning |
Causative agent (attribute) |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
1 |
Poisoning by dihydrocodeine |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Accidental poisoning by dihydrocodeine |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Intentional poisoning by dihydrocodeine |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Poisoning caused by dihydrocodeine of undetermined intent |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Nalbuphine poisoning |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Accidental nalbuphine poisoning |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Intentional nalbuphine poisoning |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
intoxication par la nalbuphine d'intention indéterminée |
Causative agent (attribute) |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Levorphanol (substance) |
Is a |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Dihydrocodeine (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Kaolin and morphine mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 15 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg/5mL oral unit dose vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg/5mL oral unit dose vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg/5mL oral unit dose vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg/5mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20mg/sachet granules for suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg/sachet granules for suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride 15 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 60mg/sachet granules for suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg/sachet granules for suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 200mg/sachet granules for suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 90mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 120mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
sulfate de morphine 50 mg/50 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
sulfate de morphine 100 mg/50 mL, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
sulfate de morphine 50 mg/50 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
sulfate de morphine 100 mg/50 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20mg/mL concentrated oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 35mg rectal tampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 50mg rectal tampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 75mg rectal tampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 100mg rectal tampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 40mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate+atropine sulfate 10mg/600micrograms/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing kaolin and morphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate+atropine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine tartrate+cyclizine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Oral form morphine solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride 10mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 15mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 60mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Opium and Morphine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (1) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine analgesic elixirs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine simple elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine + cocaine elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine/cocaine/chlorpromazine elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (3) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (2) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg/mL extended release liposome injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30mg/30mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10mg/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 4mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 8mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|